Stroke is the third cause of death in the United States. Ischemic stroke triggers a complex series of cellular events that result in degeneration of neurons and long-term neurological damages. To this day pharmacological approaches aimed at preventing neuronal death in stroke and at protecting patients at high risk are still not available or poorly effective. Sirtuins are protein deacetylases that influence the extent of neuronal death in stroke. However, their mechanism of action is currently largely unknown. We are investigating the role of sirtuins in neuronal death in C. elegans and have been focusing on mitochondrial SIR-2.3, homologous of mammalian SIRT4.We are using well-known models of neuronal death in C. elegans including
mec-4(d)-induced cell death of touch neurons and damage of amphid sensory neurons induced by chemical ischemia. We compared the extent of cell death both in cell culture and in vivo in
sir-2.3 wild type and knock out backgrounds and found that knock out of this mitochondrial sirtuin affords neuroprotection in both models of neurodegeneration. Importantly rescue experiments demonstrated that the effect is mediated by
sir-2.3. Since sirtuins have been involved in ageing, which is in turn influenced by caloric restriction, we tested whether caloric restriction influenced neuroprotection afforded by
sir-2.3 knock-out. We thus treated cultured neurons with 2-deoxyglucose (2-DG) which mimics caloric restriction. We found that treatment with 2-DG enhanced the neuroprotective effect of knock out of
sir-2.3, but had no effect on basal level of neurodegeneration. These data suggest a synergistic effect of caloric restriction and knock-out of mitochondrial
sir-2.3. Experiments are under way to establish whether neuroprotection induced by the combination of caloric restriction and
sir-2.3 knock out is mediated by reduced Ca2+ overload in these neurons. Other pathways influenced by caloric restrictions and sirtuins are being tested for involvement in this mechanism of neuroprotection. Our work will likely identify novel targets for the treatment and the prevention of neuronal damage in stroke and other neurological disorders.